COVID-19: Lucira Health Diagnostic Kit Granted First EUA For At-Home Self-Testing

In what could be a game-changer in the fight against the coronavirus, Lucira Health has received the first-ever emergency use authorization from the US FDA for an at-home prescription diagnostic test kit for detecting SARS-CoV-2.

Test result of a Corona test. Hand turns a dice and changes the expression "positive COVID19" to "negative COVID19".

Lucira Health is the recipient of the first-ever emergency use authorization (EUA) for an at-home prescription diagnostic test kit for detecting SARS-CoV-2, the virus that causes COVID-19.

The US Food and Drug Administration granted the EUA on 17 November for the firm’s

More from Diagnostics

More from Device Area